breaking news
FDA approves Bristol Myers Squibb’s schizophrenia drug
Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s ...
Middle Eastern funds plowing billions into the hottest AI start-ups
Sovereign wealth funds out of the Middle East are emerging as key backers of Silicon Valley’s artificial intelligence darlings. Oil-rich ...
Pfizer’s cancer cachexia drug shows positive midstage trial results
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
Intel working with bankers to present board with strategic options
Pat Gelsinger, CEO Intel, speaking on CNBC’s Squawk Box at the WEF Annual Meeting in Davos, Switzerland on Jan. 16th, 2024. ...
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March ...
Ro launches GLP-1 insurance coverage checker
Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine ...
Eli Lilly (LLY) earnings Q2 2024
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by ...
Eli Lilly Zepbound, Mounjaro available after shortages, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. ...
Moderna (MRNA) earnings Q2 2024
The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images ...
Biogen (BIIB) earnings Q2 2024
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado ...
